Skip to main content
. 2006 Jan 16;5:3. doi: 10.1186/1476-4598-5-3

Table 1.

Summary of SCC Tumors

Patient # Stage Grade HIF-1α Score HIF-1α P/M TSC1/2 P/M vHL P/M
1 2 WD 2 NC Exon 41(TSC2), P/G5346C NC
2 3 UD 1 NC NC NC
3 2 WD 3 NC NC NC
4 1 WD 2 NC Exon 41(TSC2), P/G5346C NC
5 2 MD 3 Exon 12, P/C1772T Exon 41(TSC2), P/G5346C NC
6 4 UD 2 NC NC NC
7 1 WD 1 NC Exon 41(TSC2), P/G5346C NC
8 2 WD 4 NC NC NC
9 1 WD 1 NC Exon 41(TSC2), P/G5346C NC
10 2 MD 3 NC NC NC
11 3 WD 3 Exon 12, P/C1772T Exon 41(TSC2), P/G5346C NC
12 2 MD 1 NC Exon 41(TSC2), P/G5346C NC
13 1 WD 1 NC NC NC
14 1 WD NC NC NC
15 3 MD 3 Exon 12, P/G1790A NC NC
16 2 MD 1 NC NC NC
17 2 WD 2 NC NC NC
18 2 WD 3 NC Exon 40 (TSC2) 528_5255 del NC
19 1 WD 2 NC NC NC
20 4 MD 2 NC NC NC
21 3 WD 3 Exon 12, P/G1790A NC NC
22 2 WD 1 NC NC NC
23 2 WD 1 NC NC NC
24 3 WD 2 NC NC NC
25 4 MD 2 NC NC NC
26 2 MD 3 Exon 12, P/C1772T NC NC
27 2 WD 2 NC NC
28 3 WD 4 Exon 12, M/C1771A Exon 36 (TSC2) 4681 delAG 40 (TSC2) 5238_5255 del 41(TSC2) P/G5346C NC

WD-Well differentiated;MD-Moderately Well-differentiated; UD-Undifferentiated;NC-No change wild-type; P-polymorphism; M-Mutation; del-deletion